2023 Q3 Form 10-Q Financial Statement

#000171658323000192 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $0.00 $0.00
YoY Change -100.0% -100.0%
Cost Of Revenue $3.290M $2.410M
YoY Change -59.89% 75.91%
Gross Profit -$3.290M -$2.410M
YoY Change -59.87% 82.02%
Gross Profit Margin
Selling, General & Admin $21.04M $49.10M
YoY Change -41.71% 144.69%
% of Gross Profit
Research & Development $10.86M $12.60M
YoY Change 17.49% 20.17%
% of Gross Profit
Depreciation & Amortization $1.000M $700.0K
YoY Change 25.0% 0.0%
% of Gross Profit
Operating Expenses $40.07M $64.11M
YoY Change -25.16% 100.84%
Operating Profit -$40.07M -$64.11M
YoY Change -25.16% 101.13%
Interest Expense $1.441M $2.494M
YoY Change 416.49% 4518.52%
% of Operating Profit
Other Income/Expense, Net -$3.983M $3.850M
YoY Change -122.27% -94.55%
Pretax Income -$44.06M -$60.26M
YoY Change 23.58% -255.33%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$44.05M -$60.25M
YoY Change 77.67% -243.45%
Net Earnings / Revenue
Basic Earnings Per Share -$0.18 -$0.25
Diluted Earnings Per Share -$0.18 -$0.25
COMMON SHARES
Basic Shares Outstanding 244.9M shares 244.6M shares
Diluted Shares Outstanding 244.9M shares 244.6M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $137.8M $172.4M
YoY Change -55.58% -52.63%
Cash & Equivalents $110.6M $140.5M
Short-Term Investments $27.20M $31.88M
Other Short-Term Assets $1.338M $1.473M
YoY Change -71.37% -51.29%
Inventory $41.23M $44.01M
Prepaid Expenses
Receivables $297.0K $950.0K
Other Receivables $321.0K $324.0K
Total Short-Term Assets $191.2M $226.2M
YoY Change -48.92% -47.21%
LONG-TERM ASSETS
Property, Plant & Equipment $19.55M $21.89M
YoY Change -21.39% 3.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $8.328M $15.03M
YoY Change -44.59% 0.0%
Other Assets $6.056M $13.35M
YoY Change -21.25% 133.12%
Total Long-Term Assets $54.05M $58.81M
YoY Change -4.92% 12.42%
TOTAL ASSETS
Total Short-Term Assets $191.2M $226.2M
Total Long-Term Assets $54.05M $58.81M
Total Assets $245.2M $285.0M
YoY Change -43.12% -40.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.600M $7.743M
YoY Change -42.74% -0.36%
Accrued Expenses $22.89M $23.56M
YoY Change 23.17% 115.83%
Deferred Revenue $7.700M $6.800M
YoY Change 882.14% 230.74%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $37.56M $40.47M
YoY Change 25.13% 73.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.317M $16.72M
YoY Change -77.19% 171.63%
Total Long-Term Liabilities $1.317M $16.72M
YoY Change -77.19% 171.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $37.56M $40.47M
Total Long-Term Liabilities $1.317M $16.72M
Total Liabilities $67.43M $68.35M
YoY Change 8.53% -12.71%
SHAREHOLDERS EQUITY
Retained Earnings -$193.1M -$149.1M
YoY Change 1129.94% -1738.46%
Common Stock $25.00K $25.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $178.5M $217.4M
YoY Change
Total Liabilities & Shareholders Equity $245.2M $285.0M
YoY Change -43.12% -40.73%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$44.05M -$60.25M
YoY Change 77.67% -243.45%
Depreciation, Depletion And Amortization $1.000M $700.0K
YoY Change 25.0% 0.0%
Cash From Operating Activities -$30.01M -$36.05M
YoY Change -36.6% -7.06%
INVESTING ACTIVITIES
Capital Expenditures $3.270M $1.223M
YoY Change -10.85% -67.45%
Acquisitions
YoY Change
Other Investing Activities $5.000M $75.52M
YoY Change -102.09%
Cash From Investing Activities $1.730M $74.30M
YoY Change -100.71% -2077.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.00K -148.0K
YoY Change -87.73% -62.24%
NET CHANGE
Cash From Operating Activities -30.01M -36.05M
Cash From Investing Activities 1.730M 74.30M
Cash From Financing Activities -20.00K -148.0K
Net Change In Cash -28.30M 38.11M
YoY Change -90.26% -188.76%
FREE CASH FLOW
Cash From Operating Activities -$30.01M -$36.05M
Capital Expenditures $3.270M $1.223M
Free Cash Flow -$33.28M -$37.27M
YoY Change -34.75% -12.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.0021
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
526000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
526000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16719000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1901000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
68350000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
67837000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
244708119 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
244708119 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
25000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
25000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3769592 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3769592 shares
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
6446000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
6446000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
375818000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
372942000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-149094000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58598000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2898000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-153000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
217405000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
307770000 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
-706000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-711000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
216699000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
307059000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
285049000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
374896000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12597000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10483000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49098000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20065000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
64105000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
31918000 usd
us-gaap Operating Expenses
OperatingExpenses
105140000 usd
us-gaap Operating Expenses
OperatingExpenses
59259000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-64105000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-31872000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-105140000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-56325000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-160000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8415000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-801000 usd
CY2023Q2 hyzn Change In Fair Value Of Earnout Liability
ChangeInFairValueOfEarnoutLiability
916000 usd
hyzn Change In Fair Value Of Earnout Liability
ChangeInFairValueOfEarnoutLiability
69337000 usd
CY2022Q2 hyzn Equity Securities Without Readily Determinable Fair Value Annual Gain Loss
EquitySecuritiesWithoutReadilyDeterminableFairValueAnnualGainLoss
-2448000 usd
hyzn Equity Securities Without Readily Determinable Fair Value Annual Gain Loss
EquitySecuritiesWithoutReadilyDeterminableFairValueAnnualGainLoss
0 usd
hyzn Equity Securities Without Readily Determinable Fair Value Annual Gain Loss
EquitySecuritiesWithoutReadilyDeterminableFairValueAnnualGainLoss
10082000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Realized After Tax
ForeignCurrencyTransactionGainLossRealizedAfterTax
280000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Realized After Tax
ForeignCurrencyTransactionGainLossRealizedAfterTax
-1454000 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2494000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
54000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3850000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
70663000 usd
CY2023Q2 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-60255000 usd
CY2022Q2 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
38791000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-60255000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
38791000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3208000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-60248000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
41999000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-60255000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
38791000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-931000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-235000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-691000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1859000 usd
CY2022Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
303000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-61877000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
38556000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
22000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2840000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-61899000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
41396000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
244628000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
248056000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
244628000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
258265000 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
307059000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1359000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
58000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
462000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
759000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-30248000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-804000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
277001000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1628000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
53000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
154000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
845000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-60248000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-931000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
370065000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
34000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1193000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
160000 usd
CY2022Q1 hyzn Warrants Repurchased During Period Value
WarrantsRepurchasedDuringPeriodValue
31000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6523000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2295000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
211000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
362494000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
41999000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3208000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-235000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
402612000 usd
us-gaap Profit Loss
ProfitLoss
-90513000 usd
us-gaap Profit Loss
ProfitLoss
29973000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2193000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1606000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2987000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3052000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-526000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-801000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9938000 usd
hyzn Change In Fair Value Of Earnout Liabilitys
ChangeInFairValueOfEarnoutLiabilitys
-7336000 usd
hyzn Change In Fair Value Of Earnout Liabilitys
ChangeInFairValueOfEarnoutLiabilitys
-69337000 usd
hyzn Equity Securities Without Readily Determinable Fair Value Annual Gain Loss
EquitySecuritiesWithoutReadilyDeterminableFairValueAnnualGainLoss
0 usd
hyzn Equity Securities Without Readily Determinable Fair Value Annual Gain Loss
EquitySecuritiesWithoutReadilyDeterminableFairValueAnnualGainLoss
10082000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1424000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
2106000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-30000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1620000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1090000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
919000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2920000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10500000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19009000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6764000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1794000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-305000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
430000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-5995000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-214000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1986000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
4424000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
5988000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-118000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2711000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3762000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
14885000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-315000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-82058000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68880000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2684000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7652000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
16594000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
50021000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
129905000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
160648000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7652000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
40000 usd
hyzn Payment Of Finance Lease Liability
PaymentOfFinanceLeaseLiability
237000 usd
hyzn Payment Of Finance Lease Liability
PaymentOfFinanceLeaseLiability
181000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
111000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
463000 usd
hyzn Payment For Intellectual Property License Agreement Fee
PaymentForIntellectualPropertyLicenseAgreementFee
-3146000 usd
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
0 usd
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
31000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-348000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3781000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-140000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
78240000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-80453000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66790000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
449365000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145030000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
368912000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-60300000 usd
us-gaap Profit Loss
ProfitLoss
-90500000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
38800000 usd
us-gaap Profit Loss
ProfitLoss
30000000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-149100000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58600000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-82100000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68900000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
140500000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
31900000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
4500000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
15100000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.79
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
1800000 usd
us-gaap Inventory Write Down
InventoryWriteDown
2100000 usd
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5874000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4638000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4620000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
10016000 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
912000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
942000 usd
CY2023Q2 hyzn Accrued Contract Manufacturer Costs Current
AccruedContractManufacturerCostsCurrent
1383000 usd
CY2022Q4 hyzn Accrued Contract Manufacturer Costs Current
AccruedContractManufacturerCostsCurrent
1409000 usd
CY2023Q2 hyzn Contract Termination Fees Accrual Current
ContractTerminationFeesAccrualCurrent
465000 usd
CY2022Q4 hyzn Contract Termination Fees Accrual Current
ContractTerminationFeesAccrualCurrent
2688000 usd
CY2023Q2 hyzn Accrued Cancellation Fees
AccruedCancellationFees
0 usd
CY2022Q4 hyzn Accrued Cancellation Fees
AccruedCancellationFees
1192000 usd
CY2023Q2 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
7000000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3310000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23564000 usd
CY2022Q4 hyzn Equity Securities Without Readily Determinable Fair Value Initial Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueInitialAmount
4948000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
12530000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
2448000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
15030000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
0 usd
CY2022Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
0 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
0 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
12530000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2022Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
-2448000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
-2448000 usd
CY2023Q2 hyzn Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment And Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAndImpairmentLossAnnualAmount
0 usd
CY2022Q2 hyzn Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment And Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAndImpairmentLossAnnualAmount
-2448000 usd
hyzn Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment And Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAndImpairmentLossAnnualAmount
0 usd
hyzn Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment And Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAndImpairmentLossAnnualAmount
10082000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2021Q4 hyzn Litigation Contingency Number Of Class Action Lawsuits Filed
LitigationContingencyNumberOfClassActionLawsuitsFiled
3 lawsuit
CY2022Q1 hyzn Litigation Contingency Number Of Shareholder Lawsuits
LitigationContingencyNumberOfShareholderLawsuits
3 lawsuit
hyzn Number Of Stockholders Demand For Books And Records
NumberOfStockholdersDemandForBooksAndRecords
4 stockholder
CY2022Q2 hyzn Number Of Stockholders Not Filing Complaint
NumberOfStockholdersNotFilingComplaint
1 stockholder
hyzn Number Of Stockholders Demand For Books And Records
NumberOfStockholdersDemandForBooksAndRecords
4 stockholder
hyzn Number Of Stockholders Demand For Books And Records
NumberOfStockholdersDemandForBooksAndRecords
4 stockholder
hyzn Number Of Stockholders Demand For Books And Records
NumberOfStockholdersDemandForBooksAndRecords
4 stockholder
CY2023Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
2100000 eur
CY2023Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
2300000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P11Y4M2D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P11Y9M21D
CY2023Q2 hyzn Number Of Votes Allocated For Each Class A Share
NumberOfVotesAllocatedForEachClassAShare
1 vote
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
244708119 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
244708119 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
244509208 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
244509208 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
19028165 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
19028165 shares
CY2023Q2 hyzn Deposit For Fuel Cell Components
DepositForFuelCellComponents
4400000 usd
CY2022Q2 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
200000 usd
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
500000 usd
CY2023Q2 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
0 usd
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
0 usd
CY2023Q2 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
6400000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-60248000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
41999000 usd
us-gaap Net Income Loss
NetIncomeLoss
-90496000 usd
us-gaap Net Income Loss
NetIncomeLoss
35476000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
244628000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
248056000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
244585000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
247999000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10209000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10773000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
244628000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
258265000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
244585000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
258772000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14

Files In Submission

Name View Source Status
0001716583-23-000192-index-headers.html Edgar Link pending
0001716583-23-000192-index.html Edgar Link pending
0001716583-23-000192.txt Edgar Link pending
0001716583-23-000192-xbrl.zip Edgar Link pending
a102secondamendment.htm Edgar Link pending
a102secondamendment001.jpg Edgar Link pending
a102secondamendment002.jpg Edgar Link pending
a103thirdamendment.htm Edgar Link pending
a103thirdamendment001.jpg Edgar Link pending
a103thirdamendment002.jpg Edgar Link pending
a104bodagreement.htm Edgar Link pending
a104bodagreement001.jpg Edgar Link pending
a104bodagreement002.jpg Edgar Link pending
a104bodagreement003.jpg Edgar Link pending
a104bodagreement004.jpg Edgar Link pending
a104bodagreement005.jpg Edgar Link pending
a104bodagreement006.jpg Edgar Link pending
a104bodagreement007.jpg Edgar Link pending
a104bodagreement008.jpg Edgar Link pending
a104bodagreement009.jpg Edgar Link pending
a105firstamendment.htm Edgar Link pending
a105firstamendment001.jpg Edgar Link pending
a105firstamendment002.jpg Edgar Link pending
a105firstamendment003.jpg Edgar Link pending
a106bodagreement.htm Edgar Link pending
a106bodagreement001.jpg Edgar Link pending
a106bodagreement002.jpg Edgar Link pending
a106bodagreement003.jpg Edgar Link pending
a106bodagreement004.jpg Edgar Link pending
a106bodagreement005.jpg Edgar Link pending
a106bodagreement006.jpg Edgar Link pending
a106bodagreement007.jpg Edgar Link pending
a106bodagreement008.jpg Edgar Link pending
a106bodagreement009.jpg Edgar Link pending
a106bodagreement010.jpg Edgar Link pending
a107firstamendment.htm Edgar Link pending
a107firstamendment001.jpg Edgar Link pending
a107firstamendment002.jpg Edgar Link pending
a107firstamendment003.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hyzn-20230630.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hyzn-20230630.xsd Edgar Link pending
hyzn2023630ex311.htm Edgar Link pending
hyzn2023630ex312.htm Edgar Link pending
hyzn2023630ex321.htm Edgar Link pending
hyzn2023630ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
hyzn-20230630_def.xml Edgar Link unprocessable
hyzn-20230630_lab.xml Edgar Link unprocessable
hyzn-20230630_pre.xml Edgar Link unprocessable
hyzn-20230630_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hyzn-20230630_cal.xml Edgar Link unprocessable